Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Updated: Oct 19, 2026
David Amsellem's Stock Ratings
Piper Sandler Analyst
David Amsellem is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
24.0%
Smart Score
Overall Average Return Percentile
81st
Number of Ratings
100
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 09/18/2026 | AXSM | Buy Now | Axsome Therapeutics | $155.99 | 65.4% | $258 → $258 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/16/2026 | VTRS | Buy Now | Viatris | $18.39 | -29.31% | $12 → $13 | Maintains | Neutral | Get Alert | |
| 09/16/2026 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | 39.42% | $75 → $82 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/03/2026 | BIIB | Buy Now | Biogen | $236.00 | 3.81% | $225 → $245 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/20/2026 | AMGN | Buy Now | Amgen | $424.94 | 7.54% | $427 → $457 | Maintains | Overweight | Get Alert | |
| 08/20/2026 | ABBV | Buy Now | AbbVie | $282.60 | 7.22% | $298 → $303 | Maintains | Overweight | Get Alert | |
| 08/07/2026 | DFTX | Buy Now | Definium Therapeutics | $33.00 | 127.27% | $73 → $75 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/07/2026 | COLL | Buy Now | Collegium Pharmaceutical | $23.01 | 86.88% | $45 → $43 | Reiterates | Neutral → Neutral | Get Alert | |
| 08/07/2026 | AMPH | Buy Now | Amphastar Pharma | $26.14 | -23.49% | $21 → $20 | Maintains | Neutral | Get Alert | |
| 08/04/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | 48.73% | $301 → $310 | Maintains | Overweight | Get Alert | |
| 07/31/2026 | NBIX | Buy Now | Neurocrine Biosciences | $136.98 | 53.31% | $207 → $210 | Maintains | Overweight | Get Alert | |
| 07/30/2026 | CORT | Buy Now | Corcept Therapeutics | $112.10 | 47.19% | $88 → $165 | Reiterates | Overweight → Overweight | Get Alert | |
| 07/28/2026 | TEVA | Buy Now | Teva Pharmaceutical Indus | $41.12 | 7% | $42 → $44 | Maintains | Overweight | Get Alert | |
| 07/28/2026 | ALKS | Buy Now | Alkermes | $42.97 | 51.27% | $43 → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 07/24/2026 | DFTX | Buy Now | Definium Therapeutics | $33.00 | 121.21% | $48 → $73 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/23/2026 | ABBV | Buy Now | AbbVie | $282.60 | 5.45% | $298 → $298 | Reiterates | Overweight → Overweight | Get Alert | |
| 05/22/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | 44.41% | $232 → $301 | Maintains | Overweight | Get Alert | |
| 05/15/2026 | BIIB | Buy Now | Biogen | $236.00 | -4.66% | $214 → $225 | Reiterates | Overweight → Overweight | Get Alert | |
| 05/14/2026 | AMGN | Buy Now | Amgen | $424.94 | 0.48% | $432 → $427 | Maintains | Overweight | Get Alert | |
| 05/14/2026 | ABBV | Buy Now | AbbVie | $282.60 | 5.45% | $294 → $298 | Maintains | Overweight | Get Alert | |
| 05/11/2026 | AMPH | Buy Now | Amphastar Pharma | $26.14 | -19.66% | $25 → $21 | Reiterates | Neutral → Neutral | Get Alert | |
| 05/08/2026 | DFTX | Buy Now | Definium Therapeutics | $33.00 | 45.45% | $49 → $48 | Maintains | Overweight | Get Alert | |
| 05/06/2026 | NBIX | Buy Now | Neurocrine Biosciences | $136.98 | 51.12% | $190 → $207 | Maintains | Overweight | Get Alert | |
| 05/01/2026 | CORT | Buy Now | Corcept Therapeutics | $112.10 | -21.5% | $73 → $88 | Maintains | Overweight | Get Alert | |
| 04/30/2026 | TEVA | Buy Now | Teva Pharmaceutical Indus | $41.12 | 2.14% | $41 → $42 | Reiterates | Overweight → Overweight | Get Alert | |
| 04/28/2026 | OGN | Buy Now | Organon | $13.75 | 1.82% | $5 → $14 | Upgrade | Underweight → Neutral | Get Alert | |
| 04/23/2026 | ABBV | Buy Now | AbbVie | $282.60 | 4.03% | $299 → $294 | Maintains | Overweight | Get Alert | |
| 04/14/2026 | BIIB | Buy Now | Biogen | $236.00 | -9.32% | $177 → $214 | Upgrade | Neutral → Overweight | Get Alert | |
| 04/10/2026 | DFTX | Buy Now | Definium Therapeutics | $33.00 | 48.48% | → $49 | Initiates | → Overweight | Get Alert | |
| 03/24/2026 | ALKS | Buy Now | Alkermes | $42.97 | 0.07% | $45 → $43 | Maintains | Overweight | Get Alert | |
| 03/19/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | 11.31% | $219 → $232 | Maintains | Overweight | Get Alert | |
| 03/04/2026 | TEVA | Buy Now | Teva Pharmaceutical Indus | $41.12 | -0.29% | $40 → $41 | Reiterates | Overweight → Overweight | Get Alert | |
| 02/27/2026 | PTHS | Buy Now | Pelthos Therapeutics | $20.26 | 136.92% | → $48 | Initiates | → Overweight | Get Alert | |
| 02/23/2026 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | 27.52% | $66 → $75 | Maintains | Overweight | Get Alert | |
| 02/18/2026 | AMGN | Buy Now | Amgen | $424.94 | 1.66% | $381 → $432 | Maintains | Overweight | Get Alert | |
| 02/18/2026 | ABBV | Buy Now | AbbVie | $282.60 | 5.8% | $289 → $299 | Maintains | Overweight | Get Alert | |
| 02/09/2026 | BIIB | Buy Now | Biogen | $236.00 | -25% | $157 → $177 | Maintains | Neutral | Get Alert | |
| 01/28/2026 | VTRS | Buy Now | Viatris | $18.39 | -34.75% | $9 → $12 | Maintains | Neutral | Get Alert | |
| 01/28/2026 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | 12.22% | $62 → $66 | Maintains | Overweight | Get Alert | |
| 01/16/2026 | AXSM | Buy Now | Axsome Therapeutics | $155.99 | 42.96% | $148 → $223 | Maintains | Overweight | Get Alert | |
| 01/09/2026 | FENC | Buy Now | Fennec Pharmaceuticals | $10.27 | 75.27% | → $18 | Initiates | → Overweight | Get Alert | |
| 12/22/2025 | TEVA | Buy Now | Teva Pharmaceutical Indus | $41.12 | -2.72% | $30 → $40 | Maintains | Overweight | Get Alert | |
| 12/10/2025 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | 5.07% | $147 → $219 | Reiterates | Overweight → Overweight | Get Alert | |
| 11/25/2025 | ESPR | Buy Now | Esperion Therapeutics | — | — | → $9 | Initiates | → Overweight | Get Alert | |
| 11/21/2025 | BIIB | Buy Now | Biogen | $236.00 | -33.47% | $118 → $157 | Reiterates | Neutral → Neutral | Get Alert | |
| 11/14/2025 | AMGN | Buy Now | Amgen | $424.94 | -10.34% | $342 → $381 | Maintains | Overweight | Get Alert | |
| 11/07/2025 | XERS | Buy Now | Xeris Biopharma Holdings | $11.00 | -27.27% | $6 → $8 | Maintains | Neutral | Get Alert | |
| 11/07/2025 | AQST | Buy Now | Aquestive Therapeutics | $3.89 | 105.69% | $5 → $8 | Maintains | Overweight | Get Alert | |
| 11/05/2025 | ABBV | Buy Now | AbbVie | $282.60 | 2.26% | $284 → $289 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/31/2025 | INDV | Buy Now | Indivior | $33.77 | 21.41% | $27 → $41 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/31/2025 | AMRX | Buy Now | Amneal Pharmaceuticals | $19.36 | -32.85% | $11 → $13 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/29/2025 | NBIX | Buy Now | Neurocrine Biosciences | $136.98 | 30.68% | $175 → $179 | Maintains | Overweight | Get Alert | |
| 10/23/2025 | ALKS | Buy Now | Alkermes | $42.97 | 4.72% | $38 → $45 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/10/2025 | ABBV | Buy Now | AbbVie | $282.60 | 0.5% | $231 → $284 | Maintains | Overweight | Get Alert | |
| 10/09/2025 | SUPN | Buy Now | Supernus Pharmaceuticals | $39.84 | 63.15% | $40 → $65 | Upgrade | Neutral → Overweight | Get Alert | |
| 08/29/2025 | SUPN | Buy Now | Supernus Pharmaceuticals | $39.84 | 0.4% | $36 → $40 | Maintains | Neutral | Get Alert | |
| 08/25/2025 | AMGN | Buy Now | Amgen | $424.94 | -19.52% | $328 → $342 | Maintains | Overweight | Get Alert | |
| 08/14/2025 | BIIB | Buy Now | Biogen | $236.00 | -50% | $115 → $118 | Maintains | Neutral | Get Alert | |
| 08/12/2025 | ABBV | Buy Now | AbbVie | $282.60 | -18.26% | → $231 | Assumes | → Overweight | Get Alert | |
| 08/08/2025 | AMPH | Buy Now | Amphastar Pharma | $26.14 | -4.36% | $30 → $25 | Maintains | Neutral | Get Alert | |
| 08/01/2025 | CORT | Buy Now | Corcept Therapeutics | $112.10 | 7.94% | $131 → $121 | Maintains | Overweight | Get Alert | |
| 07/31/2025 | NBIX | Buy Now | Neurocrine Biosciences | $136.98 | 27.76% | $154 → $175 | Maintains | Overweight | Get Alert | |
| 06/27/2025 | AMGN | Buy Now | Amgen | $424.94 | -22.81% | $328 → $328 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/17/2025 | SAGE | Buy Now | Sage Therapeutics | — | — | $9 → $8.5 | Downgrade | Overweight → Neutral | Get Alert | |
| 06/12/2025 | BIIB | Buy Now | Biogen | $236.00 | -51.27% | $115 → $115 | Reiterates | Neutral → Neutral | Get Alert | |
| 05/16/2025 | AMGN | Buy Now | Amgen | $424.94 | -22.81% | $329 → $328 | Maintains | Overweight | Get Alert | |
| 05/15/2025 | OGN | Buy Now | Organon | $13.75 | 30.91% | $24 → $18 | Maintains | Overweight | Get Alert | |
| 05/09/2025 | COLL | Buy Now | Collegium Pharmaceutical | $23.01 | 60.8% | $36 → $37 | Reiterates | Neutral → Neutral | Get Alert | |
| 05/07/2025 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | -29.47% | $176 → $147 | Reiterates | Overweight → Overweight | Get Alert | |
| 05/06/2025 | NBIX | Buy Now | Neurocrine Biosciences | $136.98 | 12.43% | $160 → $154 | Reiterates | Overweight → Overweight | Get Alert | |
| 04/22/2025 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | 10.52% | → $65 | Initiates | → Overweight | Get Alert | |
| 04/03/2025 | CORT | Buy Now | Corcept Therapeutics | $112.10 | 16.86% | $128 → $131 | Maintains | Overweight | Get Alert | |
| 03/21/2025 | AMPH | Buy Now | Amphastar Pharma | $26.14 | 22.42% | $36 → $32 | Maintains | Neutral | Get Alert | |
| 03/21/2025 | OPTN | Buy Now | OptiNose | — | — | $15 → $9 | Downgrade | Overweight → Neutral | Get Alert | |
| 03/07/2025 | XERS | Buy Now | Xeris Biopharma Holdings | $11.00 | -63.64% | $3 → $4 | Reiterates | Neutral → Neutral | Get Alert | |
| 03/06/2025 | INDV | Buy Now | Indivior | $33.77 | -61.5% | $16 → $13 | Maintains | Overweight | Get Alert | |
| 03/05/2025 | VTRS | Buy Now | Viatris | $18.39 | -45.62% | $14 → $10 | Reiterates | Neutral → Neutral | Get Alert | |
| 02/27/2025 | CORT | Buy Now | Corcept Therapeutics | $112.10 | -30.42% | $67 → $78 | Maintains | Overweight | Get Alert | |
| 02/26/2025 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | -15.56% | $163 → $176 | Reiterates | Overweight → Overweight | Get Alert | |
| 02/10/2025 | AMGN | Buy Now | Amgen | $424.94 | -22.58% | $310 → $329 | Maintains | Overweight | Get Alert | |
| 02/04/2025 | AMPH | Buy Now | Amphastar Pharma | $26.14 | 37.72% | $66 → $36 | Downgrade | Overweight → Neutral | Get Alert | |
| 02/04/2025 | COLL | Buy Now | Collegium Pharmaceutical | $23.01 | 56.45% | $37 → $36 | Maintains | Neutral | Get Alert | |
| 01/17/2025 | TEVA | Buy Now | Teva Pharmaceutical Indus | $41.12 | -27.04% | $23 → $30 | Maintains | Overweight | Get Alert | |
| 01/14/2025 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | $107 → $132 | Downgrade | Overweight → Neutral | Get Alert | |
| 01/10/2025 | AVDL | Buy Now | Avadel Pharmaceuticals | — | — | $24 → $13 | Maintains | Overweight | Get Alert | |
| 01/02/2025 | SAGE | Buy Now | Sage Therapeutics | — | — | $26 → $9 | Maintains | Overweight | Get Alert | |
| 01/02/2025 | AMGN | Buy Now | Amgen | $424.94 | -27.05% | $344 → $310 | Maintains | Overweight | Get Alert | |
| 12/23/2024 | NBIX | Buy Now | Neurocrine Biosciences | $136.98 | 16.81% | $160 → $160 | Reiterates | Overweight → Overweight | Get Alert | |
| 12/12/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | -21.8% | $163 → $163 | Reiterates | Overweight → Overweight | Get Alert | |
| 12/06/2024 | VTRS | Buy Now | Viatris | $18.39 | -23.87% | $13 → $14 | Reiterates | Neutral → Neutral | Get Alert | |
| 11/21/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | -21.8% | $166 → $163 | Reiterates | Overweight → Overweight | Get Alert | |
| 11/13/2024 | OPTN | Buy Now | OptiNose | — | — | $3 → $1 | Maintains | Overweight | Get Alert | |
| 11/11/2024 | AMRX | Buy Now | Amneal Pharmaceuticals | $19.36 | -43.18% | $9 → $11 | Maintains | Overweight | Get Alert | |
| 11/11/2024 | XERS | Buy Now | Xeris Biopharma Holdings | $11.00 | -72.73% | $3 → $3 | Downgrade | Overweight → Neutral | Get Alert | |
| 10/25/2024 | INDV | Buy Now | Indivior | $33.77 | -52.62% | $15 → $16 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/25/2024 | ALKS | Buy Now | Alkermes | $42.97 | -13.89% | $38 → $37 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/11/2024 | INDV | Buy Now | Indivior | $33.77 | -55.58% | $22 → $15 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/11/2024 | COLL | Buy Now | Collegium Pharmaceutical | $23.01 | 60.8% | $37 → $37 | Reiterates | Neutral → Neutral | Get Alert | |
| 10/11/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $72.56 | -6.28% | → $68 | Initiates | → Overweight | Get Alert | |
| 09/18/2024 | CORT | Buy Now | Corcept Therapeutics | $112.10 | -40.23% | $38 → $67 | Maintains | Overweight | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved